Antioxidants as a Preventive Treatment for Epileptic Process: A Review of the Current Status

Title:Antioxidants as a Preventive Treatment for Epileptic Process: A Review of the Current Status

Volume: 12 Issue: 6

Author(s): Bostjan Martinc, Iztok Grabnar and Tomaz Vovk

Affiliation:

Keywords: Antiepileptic drugs, antioxidants, epileptogenesis, meta-analysis, neuroprotective, oxidative stress, reactive species.

Abstract: Epilepsy is known as one of the most frequent neurological diseases, characterized by an enduring predisposition to generate epileptic seizures. Oxidative stress is believed to directly participate in pathways leading to neurodegeneration, which serves as the most important propagating factor, leading to the epileptic condition and cognitive decline. Moreover, there is also a growing body of evidence showing the disturbance of antioxidant system balance and consequently increased production of reactive species in patients with epilepsy. A meta-analysis, conducted in the present review confirms an association between epilepsy and increased lipid peroxidation. Furthermore, it was also shown that some of the antiepileptic drugs could potentially be responsible for additionally increased lipid peroxidation. Therefore, it is reasonable to propose that during the epileptic process neuroprotective treatment with antioxidants could lead to less sever structural damages, reduced epileptogenesis and milder cognitive deterioration. To evaluate this hypothesis studies investigating the neuroprotective therapeutic potential of various antioxidants in cells, animal seizure models and patients with epilepsy have been reviewed. Numerous beneficial effects of antioxidants on oxidative stress markers and in some cases also neuroprotective effects were observed in animal seizure models. However, despite these encouraging results, till now only a few antioxidants have been further applied to patients with epilepsy as an add-on therapy. Based on the several positive findings in animal models, a strong need for more carefully planned, randomized, double-blind, cross-over, placebo-controlled clinical trials for the evaluation of antioxidants efficacy in patients with epilepsy is warranted.

Cite this article as:

Martinc Bostjan, Grabnar Iztok and Vovk Tomaz, Antioxidants as a Preventive Treatment for Epileptic Process: A Review of the Current Status, Current Neuropharmacology 2014; 12 (6) . https://dx.doi.org/10.2174/1570159X12666140923205715